"10.1371_journal.pone.0113371","plos one","2014-11-17T00:00:00Z","Luca Massacesi; Irene Tramacere; Salvatore Amoroso; Mario A Battaglia; Maria Donata Benedetti; Graziella Filippini; Loredana La Mantia; Anna Repice; Alessandra Solari; Gioacchino Tedeschi; Clara Milanese","Dipartimento di Neuroscienze, Psicologia, Farmaco e Salute del Bambino Università di Firenze, Firenze, Italy; Neurologia 2, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy; Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy; Dipartimento di Neuroscienze, Sezione di Farmacologia, Università Politecnica delle Marche, Ancona, Italy; Associazione Italiana Sclerosi Multipla (AISM), Fondazione Italiana Sclerosi Multipla (FISM), Genova, Italy; Dipartimento Universitario di Neurologia, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy; Unità di Neurologia - Multiple Sclerosis Center, I.R.C.C.S. Santa Maria Nascente Fondazione Don Gnocchi, Milano, Italy; Clinica Neurologica, Università di Napoli, Napoli, Italy","Conceived and designed the experiments: LM CM MDB LL GF AS. Performed the experiments: LM CM MDB GT. Analyzed the data: IT AR. Wrote the paper: GF IT LM. Critical revision of the manuscript for important intellectual content: SA MDB LL AS GT CM. Obtained funding: LM CM. Administrative, technical, and material support: MAB AR. Study supervision: LM CM.","Dr. Solari, Dr. Massacesi and Dr. Tedeschi have read the journal's policy and have the following conflicts: Dr. Solari was a board member for Novartis, Biogenidec and Merck Serono, and has received speaker honoraria from Sanofi-Aventis. Dr. Massacesi has received reimbursements for meeting participation or educational grants from Biogen-Idec, Merk-Serono, Sanofi-Aventis and Novartis. In addition, he is a member of the Scientific Advisory Group Neurology of the European Medicine Agency (EMA) and of the Italian Medicine Agency (Agenzia Italiana del Farmaco, AIFA) Advisory Committee on Neurology, but the opinions included in this paper do not involve this activity. Dr. Tedeschi has received reimbursements for meeting participation or educational grants from Biogen-Idec, Merk-Serono, Sanofi-Aventis and Novartis. In addition, he was a member of the Italian Medicine Agency (Agenzia Italiana del Farmaco, AIFA) Advisory Committee on Neurology, but the opinions included in this paper do not involve this activity. All the other authors have declared that no competing interests exist. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","11","Luca Massacesi","LM",11,FALSE,6,4,2,3,TRUE,FALSE,FALSE,0,NA,FALSE
